Related Experiment Video
Updated: Jun 8, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Tumour Load in Advanced Ovarian Cancer Patients and Its Validation by Radiological Peritoneal Cancer Index (PCI)
Uzma Chishti1, Humaira Aziz1, Imrana Masroor1
1Department of Obstetrics and Gynaecology, The Aga Khan University Hospital, Karachi, Pakistan.
Radiological Peritoneal Cancer Index (PCI) accurately predicts surgical outcomes in advanced ovarian cancer. A lower PCI score (<10) indicates less residual disease, shorter surgery, and fewer complications, aiding treatment decisions.
Area of Science:
- Oncology
- Surgical Oncology
- Radiology
Background:
- Advanced ovarian cancer often presents with peritoneal carcinomatosis, posing challenges for surgical management.
- Accurate assessment of tumor burden is crucial for surgical planning and predicting outcomes.
Purpose of the Study:
- To validate the radiological Peritoneal Cancer Index (PCI) score against the surgical PCI score.
- To assess the non-invasive predictive capability of radiological PCI for surgical outcomes in advanced ovarian cancer.
Main Methods:
- A descriptive study involving 26 patients with advanced-stage ovarian cancer.
- Radiological PCI scores were determined pre-operatively and compared with intra-operative surgical PCI scores.
- Correlation analysis and Bland-Altman plots were used to assess agreement and bias.
Main Results:
- The interclass correlation between radiological and surgical PCI was 0.52 (95% CI: 0.17-0.75).
- A radiological PCI score <10 was associated with 90% chance of no residual disease, shorter operative times, reduced blood loss, and fewer complications.
- The Bland-Altman plot showed a bias of 1.115 (95% CI: 4.61) between the two scoring methods.
Conclusions:
- The radiological Peritoneal Cancer Index is an effective non-invasive tool for predicting surgical success and residual disease in advanced ovarian cancer.
- Utilizing radiological PCI can assist in optimizing surgical timing and planning for patients with advanced ovarian cancer.
More Related Videos
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
10:21A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023